HIV-1 capture and antigen presentation by dendritic cells: Enhanced viral capture does not correlate with better T cell activation

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 6036-6045

  Rodriguez Plata, Maria T ^a   Urrutia, Alejandra ^b   Cardinaud, Sylvain ^b   Buzón, Maria J ^a   Izquierdo Useros, Nuria ^a   Prado, Julia G ^a   Puertas, Maria C ^a   Erkizia, Itziar ^a   Coulon, Pierre Grégoire ^b   Cedeño, Samandhy ^a   Clotet, Bonaventura ^a   Moris, Arnaud ^b   Martinez Picado, Javier ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSERM   (France)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A1 ANTIGEN; HLA A2 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME DEFICIENCY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION;

ANTIGEN PRESENTATION; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; T-LYMPHOCYTES;

EID: 84862593035     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200267     Document Type: Article

References (55)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. (Pubitemid 28155090)
2. Ueno, H., E. Klechevsky, R. Morita, C. Aspord, T. Cao, T. Matsui, T. Di Pucchio, J. Connolly, J.W. Fay, V. Pascual, et al. 2007. Dendritic cell subsets in health and disease. Immunol. Rev. 219: 118-142. (Pubitemid 47393528)
3. Banchereau, J., and A. K. Palucka. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5: 296-306. (Pubitemid 40516155)
4. Wu, L., and V. N. KewalRamani. 2006. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 6: 859-868.
5. Granelli-Piperno, A., E. Delgado, V. Finkel, W. Paxton, and R. M. Steinman. 1998. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72: 2733-2737. (Pubitemid 28175508)
6. Izquierdo-Useros, N., J. Blanco, I. Erkizia, M. T. Fernández- Figueras, F. E. Borràs, M. Naranjo-Gómez, M. Bofill, L. Ruiz, B. Clotet, and J. Martinez- Picado. 2007. Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission. J. Virol. 81: 7559-7570. (Pubitemid 47047842)
7. McDonald, D., L. Wu, S. M. Bohks, V. N. KewalRamani, D. Unutmaz, and T. J. Hope. 2003. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300: 1295-1297. (Pubitemid 36618241)
8. Sanders, R. W., E. C. de Jong, C. E. Baldwin, J. H. Schuitemaker, M. L. Kapsenberg, and B. Berkhout. 2002. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J. Virol. 76: 7812-7821. (Pubitemid 34761003)
9. Yu, H. J., M. A. Reuter, and D. McDonald. 2008. HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog. 4: e1000134.
10. Izquierdo-Useros, N., M. Naranjo-Gómez, J. Archer, S. C. Hatch, I. Erkizia, J. Blanco, F. E. Borràs, M. C. Puertas, J. H. Connor, M. T. Fernández-Figueras, et al. 2009. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 113: 2732-2741.
11. Izquierdo-Useros, N., M. Naranjo-Gómez, I. Erkizia, M. C. Puertas, F. E. Borràs, J. Blanco, and J. Martinez-Picado. 2010. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLoS Pathog. 6: e1000740.
12. Izquierdo-Useros, N., M. C. Puertas, F. E. Borràs, J. Blanco, and J. Martinez- Picado. 2011. Exosomes and retroviruses: the chicken or the egg? Cell. Microbiol. 13: 10-17.
13. Cavrois, M., J. Neidleman, J. F. Kreisberg, and W. C. Greene. 2007. In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog. 3: e4.
14. Ahlers, J. D., and I. M. Belyakov. 2009. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines. Trends Mol. Med. 15: 263-274.
15. Kaliński, P., C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20: 561-567.
16. Dong, C., A. M. Janas, J. H. Wang, W. J. Olson, and L. Wu. 2007. Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection. J. Virol. 81: 11352-11362. (Pubitemid 47536106)
17. Wang, J. H., A. M. Janas, W. J. Olson, and L. Wu. 2007. Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells. J. Virol. 81: 8933-8943. (Pubitemid 47311437)
18. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371. (Pubitemid 44924494)
19. Reuter, M. A., N. D. Pecora, C. V. Harding, D. H. Canaday, and D. McDonald. 2010. Mycobacterium tuberculosis promotes HIV trans-infection and suppresses major histocompatibility complex class II antigen processing by dendritic cells. J. Virol. 84: 8549-8560.
20. Oshiro, T. M., A. de Almeida, and A. J. da Silva Duarte. 2009. Dendritic cell immunotherapy for HIV infection: from theory to reality. Immunotherapy 1: 1039-1051.
21. Moris, A., A. Pajot, F. Blanchet, F. Guivel-Benhassine, M. Salcedo, and O. Schwartz. 2006. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108: 1643-1651. (Pubitemid 44316133)
22. Moris, A., C. Nobile, F. Buseyne, F. Porrot, J. P. Abastado, and O. Schwartz. 2004. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103: 2648-2654. (Pubitemid 38393020)
23. Buzón, M. J., J. Dalmau, M. C. Puertas, J. Puig, B. Clotet, and J. Martinez- Picado. 2010. The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates. AIDS 24: 17-25.
24. Llano, A., N. Frahm, and C. Brander. 2009. How to optimally define optimal cytotoxic t-lymphocyte epitopes in HIV infection? In HIV Molecular Immunology 2009. B. Korber, C. Brander, B. Haynes, R. Koup, J. Moore, B. Walker, W. Watkins, and K. Yusim, eds. Los Alamos National Laboratory, Los Alamos, NM. p. 1-3-5.
25. Iversen, A. K., G. Stewart-Jones, G. H. Learn, N. Christie, C. Sylvester-Hviid, A. E. Armitage, R. Kaul, T. Beattie, J. K. Lee, Y. Li, et al. 2006. Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat. Immunol. 7: 179-189. (Pubitemid 43135884)
26. Zhang, Y. J., T. Hatziioannou, T. Zang, D. Braaten, J. Luban, S. P. Goff, and P. D. Bieniasz. 2002. Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection. J. Virol. 76: 6332-6343. (Pubitemid 34556328)
27. Cavrois, M., C. De Noronha, and W. C. Greene. 2002. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20: 1151-1154. (Pubitemid 35285446)
28. Izquierdo-Useros, N., O. Esteban, M. T. Rodriguez-Plata, I. Erkizia, J. G. Prado, J. Blanco, M. F. García-Parajo, and J. Martinez-Picado. 2011. Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. Traffic 12: 1702-1713.
29. Ahlers, J. D., and I. M. Belyakov. 2009. Strategies for optimizing targeting and delivery of mucosal HIV vaccines. Eur. J. Immunol. 39: 2657-2669.
30. Palucka, K., J. Banchereau, and I. Mellman. 2010. Designing vaccines based on biology of human dendritic cell subsets. Immunity 33: 464-478.
31. Langenkamp, A., M. Messi, A. Lanzavecchia, and F. Sallusto. 2000. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1: 311-316.
32. Kaliński, P., P. L. Vieira, J. H. Schuitemaker, E. C. de Jong, and M. L. Kapsenberg. 2001. Prostaglandin E(2) is a selective inducer of interleukin- 12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97: 3466-3469.
33. Buseyne, F., S. Le Gall, C. Boccaccio, J. P. Abastado, J. D. Lifson, L. O. Arthur, Y. Rivière, J. M. Heard, and O. Schwartz. 2001. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 7: 344-349. (Pubitemid 32224351)
34. Sabado, R. L., E. Babcock, D. G. Kavanagh, V. Tjomsland, B. D. Walker, J. D. Lifson, N. Bhardwaj, and M. Larsson. 2007. Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1. Eur. J. Immunol. 37: 1752-1763. (Pubitemid 47065115)
35. Cavrois, M., J. Neidleman, J. F. Kreisberg, D. Fenard, C. Callebaut, and W. C. Greene. 2006. Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J. Virol. 80: 1992-1999. (Pubitemid 43228739)
36. Frank, I., M. Piatak, Jr., H. Stoessel, N. Romani, D. Bonnyay, J. D. Lifson, and M. Pope. 2002. Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs. J. Virol. 76: 2936-2951. (Pubitemid 34184879)
37. Garcia, E., M. Pion, A. Pelchen-Matthews, L. Collinson, J. F. Arrighi, G. Blot, F. Leuba, J. M. Escola, N. Demaurex, M. Marsh, and V. Piguet. 2005. HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 6: 488-501. (Pubitemid 40740388)
38. Fredericksen, B. L., B. L. Wei, J. Yao, T. Luo, and J. V. Garcia. 2002. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. J. Virol. 76: 11440-11446. (Pubitemid 35231300)
39. Delamarre, L., H. Holcombe, and I. Mellman. 2003. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198: 111-122. (Pubitemid 36870191)
40. Turville, S. G., J. J. Santos, I. Frank, P. U. Cameron, J. Wilkinson, M. Miranda- Saksena, J. Dable, H. Stössel, N. Romani, M. Piatak, Jr., et al. 2004. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103: 2170-2179. (Pubitemid 38326235)
41. Blander, J. M., and R. Medzhitov. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
42. Manickasingham, S., and C. Reis e Sousa. 2000. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo. J. Immunol. 165: 5027-5034.
43. Trombetta, E. S., M. Ebersold, W. Garrett, M. Pypaert, and I. Mellman. 2003. Activation of lysosomal function during dendritic cell maturation. Science 299: 1400-1403. (Pubitemid 36254654)
44. Laguette, N., B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Ségéral, A. Yatim, S. Emiliani, O. Schwartz, and M. Benkirane. 2011. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
45. Pion, M., A. Granelli-Piperno, B. Mangeat, R. Stalder, R. Correa, R. M. Steinman, and V. Piguet. 2006. APOBEC3G/3F mediates intrinsic resistance of monocytederived dendritic cells to HIV-1 infection. J. Exp. Med. 203: 2887-2893. (Pubitemid 46026166)
46. Connolly, N. C., B. A. Colleton, and C. R. Rinaldo. 2007. Treating HIV-1 infection with dendritic cells. Curr. Opin. Mol. Ther. 9: 353-363. (Pubitemid 47255668)
47. Rinaldo, C. R. 2009. Dendritic cell-based human immunodeficiency virus vaccine. J. Intern. Med. 265: 138-158.
48. Johnson, A. G.,M. Tomai, L. Solem, L. Beck, and E. Ribi. 1987. Characterization of a nontoxic monophosphoryl lipid A. Rev. Infect. Dis. 9(Suppl. 5): S512-S516.
49. Steers, N. J., K. K. Peachman, S. McClain, C. R. Alving, and M. Rao. 2009. Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines. Vaccine 27: 6939-6949.
50. De Becker, G., V. Moulin, B. Pajak, C. Bruck, M. Francotte, C. Thiriart, J. Urbain, and M. Moser. 2000. The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells. Int. Immunol. 12: 807-815. (Pubitemid 30410453)
51. Ismaili, J., J. Rennesson, E. Aksoy, J. Vekemans, B. Vincart, Z. Amraoui, F. Van Laethem, M. Goldman, and P. M. Dubois. 2002. Monophosphoryl lipid A activates both human dendritic cells and T cells. J. Immunol. 168: 926-932. (Pubitemid 34049597)
52. Ten Brinke, A., M. L. Karsten, M. C. Dieker, J. J. Zwaginga, and S. M. van Ham. 2007. The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization. Vaccine 25: 7145-7152.
53. Rossio, J. L., M. T. Esser, K. Suryanarayana, D. K. Schneider, J. W. Bess, Jr., G. M. Vasquez, T. A. Wiltrout, E. Chertova, M. K. Grimes, Q. Sattentau, et al. 1998. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72: 7992-8001. (Pubitemid 28421792)
54. Larsson, M., J. F. Fonteneau, M. Lirvall, P. Haslett, J. D. Lifson, and N. Bhardwaj. 2002. Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. AIDS 16: 1319-1329. (Pubitemid 34722063)
55. Lu, W., and J. M. Andrieu. 2001. In vitro human immunodeficiency virus eradication by autologous CD8(+) T cells expanded with inactivated-virus-pulsed dendritic cells. J. Virol. 75: 8949-8956. (Pubitemid 32851899)